Page last updated: 2024-11-04

imatinib and Parkinson Disease

imatinib has been researched along with Parkinson Disease in 1 studies

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ray, S1
Bender, S1
Kang, S1
Lin, R1
Glicksman, MA1
Liu, M1

Other Studies

1 other study available for imatinib and Parkinson Disease

ArticleYear
The Parkinson disease-linked LRRK2 protein mutation I2020T stabilizes an active state conformation leading to increased kinase activity.
    The Journal of biological chemistry, 2014, May-09, Volume: 289, Issue:19

    Topics: Adenosine Triphosphate; Amino Acid Substitution; Animals; Enzyme Stability; Humans; Leucine-Rich Rep

2014